Norman Moore, Ph.D., is the scientific director of infectious disease for Alere. Dr. Moore plays an integral role in Alere’s antimicrobial stewardship campaign (Test Target Treat™), which focuses on educating healthcare professionals on the role of rapid diagnostics in enabling improved treatment decisions as a way to combat the antibiotic resistance crisis.
Dr. Moore holds multiple patents and was the original inventor of the rapid urinary antigen tests for Legionella and S. pneumonia, among other assays. He has served on multiple National Institute of Allergy and Infectious Diseases (NIAID) grant committees, the Centers for Disease Control and Prevention (CDC) guideline group for rapid influenza testing, the Clinical and Laboratory Standards Institute guideline committee for point-of-care infectious disease testing, and the College of American Pathology Point-of-Care Committee. Most recently, Dr. Moore was appointed to the Expert Panel on Point-of-Care Testing for the Clinical and Laboratory Standards Institute (CLSI). He is a frequent speaker at industry events and publishes widely on topics related to antibiotic stewardship and point-of-care testing for infectious diseases.